Radionetics Oncology
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
70 Willow Rd # 200, Menlo Park, Californ...Phone Number
(858) 218-6617Website
www.radionetics.comRevenue
$8.1 MillionIndustry
About Radionetics Oncology
Radionetics Oncology Org Chart
Is Radionetics Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Radionetics Oncology recently announced quarterly report
Product Launch: Get notified when Radionetics Oncology launches new products
Check if Radionetics Oncology has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Radionetics Oncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Radionetics Oncology
Radionetics Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Radionetics Oncology had a recent Job posting/layoffs
Check out if Radionetics Oncology is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Radionetics Oncology
Find 2 more new buyers
Company Profile Activity
Activity Insights
Radionetics Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Radionetics Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Radionetics Oncology.
Radionetics Oncology financials insights
Gather financial insights about Radionetics Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$52.5M
Radionetics Oncology Tech Stack
A closer look at the technologies used by Radionetics Oncology
Most Recent Scoops
Radionetics Oncology News & Media
Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech | BioSpace
Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right to acquire the biotech for $1 billion.Radionetics Oncology Enters Into Strategic Agreement With Lilly
SAN DIEGO--(BUSINESS WIRE)--Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted radiopharmaceuticals to treat a broad range of solid tumors, announced today the formation of a strategic relationship with Eli Lilly and Company to take forward Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals. Under the terms of the agreement, Radionetics received a $140 million upfront cash payment. As
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Radionetics Oncology
Based out of California, Radionetics Oncology, is a radiopharmaceutical company with a focus on oncology.... Read More